Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Barras

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|July 11, 2014
A WXW motif is required for the anticancer activity of the TAT-RasGAP317-326 peptideDavid Barras, Nadja Chevalier, Vincent Zoete, et al.
Frontiers in Microbiology|June 23, 2017
The Anticancer Peptide TAT-RasGAP<sub>317-326</sub> Exerts Broad Antimicrobial ActivityMathieu Heulot, Nicolas Jacquier, Sébastien Aeby, et al.
Revue Medicale Suisse|March 8, 2016
[2015 literature findings in general internal medicine]David Barras, Élodie Saillen, Éric Mercier, et al.
The Journal of Experimental Medicine|July 27, 2016
High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survivalDaniel T Utzschneider, Francesca Alfei, Patrick Roelli, et al.
Frontiers in Immunology|September 15, 2016
A Well-Controlled Experimental System to Study Interactions of Cytotoxic T Lymphocytes with Tumor CellsNatalie J Neubert, Charlotte Soneson, David Barras, et al.
Oncotarget|September 8, 2016
The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent mannerMathieu Heulot, Nadja Chevalier, Julien Puyal, et al.
Cancer Research|February 2, 2021
Gain of HIF1 Activity and Loss of miRNA <i>let-7d</i> Promote Breast Cancer Metastasis to the Brain via the PDGF/PDGFR AxisChristof B Wyss, Nathalie Duffey, Sanam Peyvandi, et al.
Cancer Research|January 21, 2017
Broad and Conserved Immune Regulation by Genetically Heterogeneous Melanoma CellsNatalie J Neubert, Laure Tillé, David Barras, et al.
BMC Cancer|October 12, 2016
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastomaMarjorie Flahaut, Nicolas Jauquier, Nadja Chevalier, et al.
Oncogene|December 15, 2018
Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancerQiang Lan, Sanam Peyvandi, Nathalie Duffey, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|July 11, 2014
A WXW motif is required for the anticancer activity of the TAT-RasGAP317-326 peptideDavid Barras, Nadja Chevalier, Vincent Zoete, et al.
Frontiers in Microbiology|June 23, 2017
The Anticancer Peptide TAT-RasGAP<sub>317-326</sub> Exerts Broad Antimicrobial ActivityMathieu Heulot, Nicolas Jacquier, Sébastien Aeby, et al.
Revue Medicale Suisse|March 8, 2016
[2015 literature findings in general internal medicine]David Barras, Élodie Saillen, Éric Mercier, et al.
The Journal of Experimental Medicine|July 27, 2016
High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survivalDaniel T Utzschneider, Francesca Alfei, Patrick Roelli, et al.
Frontiers in Immunology|September 15, 2016
A Well-Controlled Experimental System to Study Interactions of Cytotoxic T Lymphocytes with Tumor CellsNatalie J Neubert, Charlotte Soneson, David Barras, et al.
Oncotarget|September 8, 2016
The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent mannerMathieu Heulot, Nadja Chevalier, Julien Puyal, et al.
Cancer Research|February 2, 2021
Gain of HIF1 Activity and Loss of miRNA <i>let-7d</i> Promote Breast Cancer Metastasis to the Brain via the PDGF/PDGFR AxisChristof B Wyss, Nathalie Duffey, Sanam Peyvandi, et al.
Cancer Research|January 21, 2017
Broad and Conserved Immune Regulation by Genetically Heterogeneous Melanoma CellsNatalie J Neubert, Laure Tillé, David Barras, et al.
BMC Cancer|October 12, 2016
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastomaMarjorie Flahaut, Nicolas Jauquier, Nadja Chevalier, et al.
Oncogene|December 15, 2018
Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancerQiang Lan, Sanam Peyvandi, Nathalie Duffey, et al.
Pageof 5